All posts tagged: Phase 2 LUMINA-1

Phase 2 LUMINA-1

Regeneron Publishes Peer-Reviewed Results of Phase 2 LUMINA-1 Clinical Trial

On September 28, 2023, Regeneron published the results of their Phase 2 LUMINA-1 Clinical Trial of the drug garetosmab in Nature Medicine, a peer-reviewed publication. Regeneron also published clinical pharmacology results from the LUMINA-1 Trial in the Journal of Clinical Pharmacology. Also on September 28, Vanderbilt University Medical Center, one of the sites for the LUMINA-1 Trial, issued […]

Read more